Effects of drotrecogin alfa activated on micro circulatory alterations in patients with severe sepsis
Effects of drotrecogin alfa activated on micro circulatory alterations in patients with severe sepsis
复制标题
DOI:
10.1097/01.ccm.0000220498.48773.3c
复制
发表时间:
2006-07-01
影响因子:
8.8
通讯作者:
Vincent, Jean-Louis
中科院分区:
文献类型:
--
作者:
de Backer, Daniel;Verdant, Colin;Vincent, Jean-Louis
Objective: Microvascular alterations may play an important role in the development of sepsis-induced organ dysfunction. Drotrecogin alfa activated (DAA) improves outcome in patients with severe sepsis, but its precise mechanism of action is not entirely defined. We investigated whether DAA can influence microcirculatory alterations in patients with severe sepsis.Design: Prospective, nonrandomized study.Setting. A 31-bed, medico-surgical intensive care unit of a university hospital.Patients: Forty adult patients with severe sepsis who met the EU criteria for DAA administration.Interventions. Twenty patients received the drug (DAA) and 20 had a contra indication to DAA administration (control).Measurements and Main Results. An orthogonal polarization spectral imaging technique was used to visualize the sublingual microcirculation. In all patients, measurements were obtained at baseline, 4 hrs later, and then every 24 hrs for up to 7 days. In patients receiving DAA, measurements were also obtained just before and 4 hrs after the end of OAA infusion. The two groups were well matched for severity of disease, number of failing organs, and the degree of microvascular alterations at baseline. The proportion of perfused capillaries increased in the DAA treated patients already at 4 hrs (from 64% [51-80%] to 84% [71-88%], p